28 April: biosimilars, managing pharmaceutical waste, & evaluating imported unlicensed drugs

Gary Hodgson, Medicines Advice pharmacist at SPS, presents a summary of the resources published by SPS between 18th and 24th April. To easily find a list of newly published pages go to sps.nhs.uk, select ‘search’, click in the search bar, and press enter Quick links to highlighted resources:    Preparing to use omalizumab biosimilar Adcomfo, a second omalizumab biosimilar alongside Omlyclo, is now licensed. We offer general information and implementation advice. https://www.sps.nhs.uk/articles/preparing-to-use-omalizumab-biosimilar/ The licence and supporting evidence for omalizumab biosimilar Adcomfo, a second omalizumab biosimilar alongside Omlyclo, is now licensed. Review its indications, evidence, and main differences. https://www.sps.nhs.uk/articles/the-licence-and-supporting-evidence-for-omalizumab-biosimilar/ The licence and supporting evidence for denosumab 60mg biosimilars Denosumab 60mg biosimilars are licensed. Learn about indications, formulations, supporting evidence and differences. https://www.sps.nhs.uk/articles/the-licence-and-supporting-evidence-for-denosumab-60mg-biosimilars/ Managing pharmaceutical waste Guidance and principles for managing waste generated from the use of medicines. https://www.sps.nhs.uk/articles/managing-pharmaceutical-waste/ Next events – forthcoming webinars and conferences           https://www.sps.nhs.uk/home/events/next-events/          Join our new WhatsApp channel to stay up to date with our latest news and updates     https://whatsapp.com/channel/0029VbBslvuJpe8aH3n7Zu1i     Podcast description:         NHS Specialist Pharmacy Service serves healthcare professionals across the NHS who are involved in all aspects of buying, making and using medicines. Our motto is 'do once and share'.